BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 31594669)

  • 21. Corrigendum to "Effects of menstrual cycle on background parenchymal enhancement and detectability of breast cancer on dynamic contrast-enhanced breast MRI: A multicenter study of an Asian population" [Eur. J. Radiol. 110 (2019) 130-135].
    Kamitani T; Yabuuchi H; Kanemaki Y; Tozaki M; Sonomura T; Mizukoshi W; Nakata W; Shimono T; Urano M; Yamano T; Kato F; Kuchiki M; Shiraga N; Yanagita H; Katsuda E; Kataoka M; Yamaguchi K; Horikoshi T; Gomi T; Nozaki M; Shiotani M; Amano M; Saigusa H; Sadaoka S; Kamiya H; Kubo M; Yamashita N; Yamamoto H; Honda H
    Eur J Radiol; 2019 May; 114():192. PubMed ID: 30954326
    [No Abstract]   [Full Text] [Related]  

  • 22. Corrigendum to "Improved depiction of atherosclerotic carotid artery stenosis in virtual monoenergetic reconstructions of venous phase dual-layer computed tomography in comparison to polyenergetic reconstructions" [Eur. J. Radiol. 100 (March) (2018) 36-42].
    Zopfs D; Lennartz S; Laukamp K; Große Hokamp N; Mpotsaris A; Maintz D; Borggrefe J; Neuhaus V
    Eur J Radiol; 2018 Sep; 106():209. PubMed ID: 30031621
    [No Abstract]   [Full Text] [Related]  

  • 23. Corrigendum to "Detection of visual and frontoparietal network perfusion deficits in Parkinson's disease dementia" [Eur. J. Radiol. 144 (2021) 109985].
    Azamat S; Arslan DB; Erdogdu E; Kicik A; Cengiz S; Eryürek K; Tufekcioğlu Z; Bilgic B; Hanagasi H; Demiralp T; Gurvit H; Ozturk-Isik E
    Eur J Radiol; 2022 Dec; 157():110570. PubMed ID: 36327858
    [No Abstract]   [Full Text] [Related]  

  • 24. Corrigendum to "MRI radiomics for the preoperative evaluation of lymphovascular invasion in breast cancer: A meta-analysis" [Eur. J. Radiol. 168 (2023) 111127].
    Ma Q; Li Z; Li W; Chen Q; Liu X; Feng W; Lei J
    Eur J Radiol; 2024 Jan; 170():111226. PubMed ID: 38056346
    [No Abstract]   [Full Text] [Related]  

  • 25. Corrigendum to "Is there a role for perfusion imaging in assessing treatment response following ablative therapy of small renal masses-A systematic review" [Eur. J. Radiol. Open 5 (2018) 102-107].
    Withey SJ; Gariani J; Reddy K; Prezzi D; Kelly-Morland C; Ilyas S; Adam A; Goh V
    Eur J Radiol Open; 2019; 6():e1. PubMed ID: 31886320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Corrigendum to "COV is a readily available quantitative indicator of metabolic heterogeneity for predicting survival of patients with early and locally advanced NSCLC manifesting as central lung cancer" [Eur. J. Radiol. 132 (2020) 109338].
    Zhao P; Pan Z; Yu T
    Eur J Radiol; 2020 Dec; 133():109401. PubMed ID: 33199189
    [No Abstract]   [Full Text] [Related]  

  • 27. Corrigendum to "Effect of visceral fat area on the accuracy of preoperative CT-N staging of colorectal cancer" [Eur. J. Radiol. 168 (2023) 111131].
    Xie M; Liu G; Dong Y; Yu L; Song R; Zhang W; Zhang Y; Huang S; He J; Xiao Y; Long L
    Eur J Radiol; 2024 Jan; 170():111253. PubMed ID: 38159330
    [No Abstract]   [Full Text] [Related]  

  • 28. Corrigendum to "INternational Soft Tissue saRcoma ConsorTium (INSTRuCT) consensus statement: Imaging recommendations for the management of rhabdomyosarcoma" [Eur. J. Radiol. 166 (2023) 111012].
    Schoot RA; van Ewijk R; von Witzleben AA; Kao SC; Hans Merks JHM; Morosi C; Pace E; Shulkin BL; Ferrari A; von Kalle T; van Rijn RR; Weiss AR; Sparber-Sauer M; Ter Horst SAJ; Beth McCarville M
    Eur J Radiol; 2023 Nov; 168():111108. PubMed ID: 37774530
    [No Abstract]   [Full Text] [Related]  

  • 29. Corrigendum to "Overview of trials on artificial intelligence algorithms in breast cancer screening - A roadmap for international evaluation and implementation" [Eur. J. Radiol. 167 (2023) 111087].
    van Nijnatten TJA; Payne NR; Hickman SE; Ashrafian H; Gilbert FJ
    Eur J Radiol; 2024 Jan; 170():111202. PubMed ID: 37988959
    [No Abstract]   [Full Text] [Related]  

  • 30. Corrigendum to "Atherosclerotic carotid artery disease Radiomics: A systematic review with meta-analysis and radiomic quality score assessment" [Eur. J. Radiol. 177 (2024) 111547].
    Vacca S; Scicolone R; Gupta A; Allan Wasserman B; Song J; Nardi V; Yang Q; Benson J; Lanzino G; Paraskevas KI; Suri JS; Saba L
    Eur J Radiol; 2024 Jun; 177():111583. PubMed ID: 38944908
    [No Abstract]   [Full Text] [Related]  

  • 31. Corrigendum to "Evaluation of breast cancer malignancy, prognostic factors and molecular subtypes using a continuous-time random-walk MR diffusion model" [Eur. J. Radiol. 166 (2023) 111003].
    Chang H; Wang D; Li Y; Xiang S; Yang YX; Kong P; Fang C; Ming L; Wang X; Zhang C; Jia W; Yan Q; Liu X; Zeng Q
    Eur J Radiol; 2023 Dec; 169():111158. PubMed ID: 37897958
    [No Abstract]   [Full Text] [Related]  

  • 32. Erratum to "Inter-exam agreement and diagnostic performance of the Korean Thyroid Imaging Reporting and Data System for thyroid nodule assessment: Real-time versus static ultrasonography" [Eur. J. Radiol. 98 (2018) 14-19].
    Bae JM; Hahn SY; Shin JH; Ko EY
    Eur J Radiol; 2018 Apr; 101():193. PubMed ID: 29459049
    [No Abstract]   [Full Text] [Related]  

  • 33. Corrigendum to "Anticoagulation status post radiofrequency ablation in a patient with hepatocellular carcinoma and delayed bleeding event" [Radiol Case Rep 15 (2020) 1381-1385].
    Adaramola O; Solomon N; Anyanwu F; Desrosiers A; Smith M
    Radiol Case Rep; 2020 Oct; 15(10):2051. PubMed ID: 32952748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Corrigendum to "Image-guided ablation of renal cell carcinoma" [Clin Radiol 72 (8) (2017) 636-644].
    Wah TM
    Clin Radiol; 2018 Jan; 73(1):121. PubMed ID: 29183651
    [No Abstract]   [Full Text] [Related]  

  • 35. Multidisciplinary treatment and survival of patients with vertebral metastases from thyroid carcinoma.
    Quan GM; Pointillart V; Palussière J; Bonichon F
    Thyroid; 2012 Feb; 22(2):125-30. PubMed ID: 22176498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of radioactive iodine in thyroid remnant ablation and treatment of well differentiated thyroid carcinoma.
    Lin JD; Kao PF; Chao TC
    Br J Radiol; 1998 Mar; 71(843):307-13. PubMed ID: 9616241
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Parameters Influencing Curative Effect of 131I Therapy on Pediatric Differentiated Thyroid Carcinoma: A Retrospective Study.
    Xu L; Liu Q; Liu Y; Pang H
    Med Sci Monit; 2016 Aug; 22():3079-85. PubMed ID: 27576533
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occult distant metastases of well-differentiated thyroid carcinoma.
    Zohar Y; Strauss M
    Head Neck; 1994; 16(5):438-42. PubMed ID: 7960741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thyroglobulin value in patients surgically treated for differentiated thyroid carcinoma.
    Mikač G; Stanković S
    Srp Arh Celok Lek; 2016; 144(7-8):397-401. PubMed ID: 29652447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid ablation with 1.1 GBq (30 mCi) iodine-131 in patients with papillary thyroid carcinoma at intermediate risk for recurrence.
    Rosário PW; Calsolari MR
    Thyroid; 2014 May; 24(5):826-31. PubMed ID: 24283207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.